'Planning for Dying While Planning for the Future': A Qualitative Evidence Review of the Severity and Unpredictability of Progression, Dying, and End of Life in People With Late-Onset Forms of Spinal Muscular Atrophy and Their Families.

Spinal muscular atrophy (SMA) is a severe, life-limiting neuromuscular condition associated with progressive disability and premature death. The condition significantly affects the quality of life of patients and their families, often resulting in psychological distress and unmet care needs. Despite growing clinical interest, qualitative evidence on the lived experiences of individuals with late-onset SMA types (II, III, IV) remains limited. This review aimed to synthesize qualitative findings on patient and family experiences in the context of complex symptomatology, unpredictable progression, burdensome caregiving, anticipatory grief, and end-of-life processes. A systematic search across EBSCO Discovery Service, Web of Science, SCOPUS, PubMed, and ProQuest identified 785 studies, of which seven met the inclusion criteria. The review followed PRISMA and SPIDER guidelines, and thematic synthesis revealed three key themes: (1) SMA as a serious condition with challenging symptomatology; (2) Severity of psychosocial impacts of SMA; (3) SMA in the context of experienced loss and premature death.

• Publication year

  2025

• Venue

  Omega

• Publication date

  2025-11-10

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/00302228251388825PMID 41208743
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding caregiver experiences with disease-modifying therapies for spinal muscular atrophy: a qualitative study

  2023cited by this paper
• Potentialities and limitations of Interprofessional Education during graduation: a systematic review and thematic synthesis of qualitative studies

  2023cited by this paper
• Parents' dilemma: A therapeutic decision for children with spinal muscular atrophy (SMA) type 1

  2022cited by this paper
• A mixed method study on the impact of living with spinal muscular atrophy in Malaysia from patients’ and caregivers’ perspectives

  2022cited by this paper
• Parents as informal caregivers of children and adolescents with spinal muscular atrophy: a systematic review of quantitative and qualitative data on the psychosocial situation, caregiver burden, and family needs

  2022cited by this paper
• Review on Spinal Muscular Atrophy

  2022cited by this paper
• Do we always need to treat patients with spinal muscular atrophy? A personal view and experience

  2021cited by this paper
• Qualitative Evidence Synthesis: Where Are We at?

  2021cited by this paper
• Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey

  2020cited by this paper
• The Burden of Spinal Muscular Atrophy on Informal Caregivers

  2020cited by this paper
• Experiences of caregivers of children with spinal muscular atrophy participating in the expanded access program for nusinersen: a longitudinal qualitative study

  2020cited by this paper
• Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy

  2020cited by this paper
• The prevalence of severe grief reactions after bereavement and their associations with mental health, physical health, and health service utilization: a population-based study

  2020cited by this paper
• New Treatments in Spinal Muscular Atrophy: Positive Results and New Challenges

  2020cited by this paper
• New and Developing Therapies in Spinal Muscular Atrophy: From Genotype to Phenotype to Treatment and Where Do We Stand?

  2020cited by this paper
• Palliative Care in SMA Type 1: A Prospective Multicenter French Study Based on Parents' Reports

  2020cited by this paper
• Economic burden of spinal muscular atrophy in the United States: a contemporary assessment

  2020cited by this paper
• Characterization of Models for Identifying Physical and Cognitive Frailty in Older Adults With Diabetes: Systematic Review and Meta-Analysis

  2020cited by this paper
• How to Perform a Systematic Literature Review: A Guide for Healthcare Researchers, Practitioners and Students

  2020cited by this paper
• “Getting ready for the adult world”: how adults with spinal muscular atrophy perceive and experience healthcare, transition and well-being

  2019cited by this paper
• Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy

  2019cited by this paper
• New Directions for SMA Therapy

  2018cited by this paper
• Identifying Opportunities to Provide Family‐centered Care for Families With Children With Type 1 Spinal Muscular Atrophy

  2018cited by this paper
• Symptom management and psychological support for families are the cornerstones of end‐of‐life care for children with spinal muscular atrophy type 1

  2018cited by this paper
• Parents' advice to healthcare professionals working with children who have spinal muscular atrophy.

  2018cited by this paper
• Financial, opportunity and psychosocial costs of spinal muscular atrophy: an exploratory qualitative analysis of Australian carer perspectives

  2018cited by this paper
• Social participation of adult patients with spinal muscular atrophy: Frequency, restrictions, satisfaction, and correlates

  2018cited by this paper
• Advances in spinal muscular atrophy therapeutics

  2018cited by this paper
• Patient Reported Impact of Symptoms in Spinal Muscular Atrophy (PRISM-SMA)

  2018cited by this paper
• Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethics.

  2017cited by this paper
• Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care.

  2017cited by this paper
• Physician driven variation in the care of children with spinal muscular atrophy type 1

  2017cited by this paper
• Disease impact on general well-being and therapeutic expectations of European Type II and Type III spinal muscular atrophy patients.

  2017cited by this paper
• Specialist paediatric palliative care services: what are the benefits?

  2017cited by this paper
• Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain

  2017cited by this paper
• A qualitative study of perceptions of meaningful change in spinal muscular atrophy

  2017cited by this paper
• P.123 - Scoliosis is an inescapable comorbidity in SMA type II. A single center experience

  2017cited by this paper
• Emerging therapies and challenges in spinal muscular atrophy

  2017cited by this paper
• Nusinersen versus Sham Control in Infantile‐Onset Spinal Muscular Atrophy

  2017cited by this paper
• A multi-source approach to determine SMA incidence and research ready population

  2017cited by this paper
• ‘A short time but a lovely little short time’: Bereaved parents' experiences of having a child with spinal muscular atrophy type 1

  2016cited by this paper
• A Review on Spinal Muscular Atrophy: Awareness, Knowledge, and Attitudes

  2016cited by this paper
• Disease burden of spinal muscular atrophy in Germany

  2016cited by this paper
• Information and treatment decisions in severe spinal muscular atrophy: A parental follow-up.

  2016cited by this paper
• Review of Spinal Muscular Atrophy (SMA) for Prenatal and Pediatric Genetic Counselors

  2016cited by this paper
• Living with illness and self-transcendence: the lived experience of patients with spinal muscular atrophy.

  2016cited by this paper
• The experiences of families living with the anticipatory loss of a school-age child with spinal muscular atrophy - the parents' perspectives.

  2016cited by this paper
• A pre-test and post-test study of the physical and psychological effects of out-of-home respite care on caregivers of children with life-threatening conditions

  2015cited by this paper
• Spinal muscular atrophies.

  2015cited by this paper
• Barriers to goals of care discussions with seriously ill hospitalized patients and their families: a multicenter survey of clinicians.

  2015cited by this paper
• A tale worth telling: the impact of the diagnosis experience on disclosure of genetic disorders.

  2015cited by this paper
• Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study

  2015cited by this paper
• Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

  2015cited by this paper
• Spinal muscular atrophy: Diagnosis and management in a new therapeutic era

  2015cited by this paper
• Qualitative research synthesis: methodological guidance for systematic reviewers utilizing meta-aggregation

  2015cited by this paper
• How communication of genetic information within the family is addressed in genetic counselling: a systematic review of research evidence

  2015cited by this paper
• Dyadic Coping of Parents After the Death of a Child

  2015cited by this paper
• The Developmental Transition From Living With to Dying From Cancer: Hospice Decision Making

  2015cited by this paper
• A mixed methods exploration of families’ experiences of the diagnosis of childhood spinal muscular atrophy

  2014cited by this paper
• Experiential knowledge of disability, impairment and illness: The reproductive decisions of families genetically at risk

  2014cited by this paper
• PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews

  2014cited by this paper
• Health-related quality of life in children and adolescents with spinal muscular atrophy in the Czech Republic.

  2014cited by this paper
• Partner-Oriented Self-Regulation Among Bereaved Parents

  2013cited by this paper
• Survival of Patients With Spinal Muscular Atrophy Type 1

  2013cited by this paper
• A Review of Pediatric Palliative Care Service Utilization in Children With a Progressive Neuromuscular Disease Who Died on a Palliative Care Program

  2013cited by this paper
• SMA-EUROPE workshop report: opportunities and challenges in developing clinical trials for spinal muscular atrophy in Europe

  2013cited by this paper
• Quality of life and anticipatory grieving among parents living with a child with cerebral palsy.

  2013cited by this paper
• [Anticipatory grief in adolescents and young adults coping with parental cancer].

  2012cited by this paper
• Childhood spinal muscular atrophy: controversies and challenges.

  2012cited by this paper
• Spinal Muscular Atrophy Type III

  2012cited by this paper
• Spinal muscular atrophy: a clinical and research update.

  2012cited by this paper
• Antizipierende Trauer bei Jugendlichen und jungen Erwachsenen mit einem an Krebs erkrankten Elternteil

  2012cited by this paper
• Beyond PICO

  2012cited by this paper
• Stress and Coping in Parents of Children and Adolescents with Spinal Muscular Atrophy

  2012cited by this paper
• Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.

  2011cited by this paper
• Self-reported quality of life has no correlation with functional status in children and adolescents with spinal muscular atrophy.

  2011cited by this paper
• Spinal muscular atrophy

  2011cited by this paper
• Validation of the Expanded Hammersmith Functional Motor Scale in Spinal Muscular Atrophy Type II and III

  2011cited by this paper
• Carrier testing for spinal muscular atrophy

  2010cited by this paper
• Living and ageing with spinal muscular atrophy type 2: Observations among an unexplored patient population

  2010cited by this paper
• Understanding the Experience of Living with Spinal Muscular Atrophy: A Qualitative Description

  2008cited by this paper
• A natural history study of late onset spinal muscular atrophy types 3b and 4

  2008cited by this paper
• Spinal muscular atrophy.

  2008cited by this paper
• Methods for the thematic synthesis of qualitative research in systematic reviews

  2008cited by this paper
• Health outcomes of bereavement.

  2007cited by this paper
• Modern Management of Spinal Muscular Atrophy

  2007cited by this paper
• Consensus Statement for Standard of Care in Spinal Muscular Atrophy

  2007cited by this paper
• Spinal muscular atrophy type 1: what are the ethics and practicality of respiratory support?

  2006cited by this paper
• Stress and well-being among parents of children with rare diseases: a prospective intervention study.

  2006cited by this paper
• Final Transitions: Family Caregiving at the End of Life

  2005cited by this paper
• Spinal Muscular Atrophy: Survival Pattern and Functional Status

  2004cited by this paper
• Spinal muscular atrophy

  2004cited by this paper
• Intelligence and cognitive function in children and adolescents with spinal muscular atrophy.

  2002cited by this paper
• Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease

  2002cited by this paper
• Genetic risk assessment in carrier testing for spinal muscular atrophy.

  2002cited by this paper
• Systematic reviews of qualitative research

  2001cited by this paper
• 59th ENMC International Workshop: Spinal Muscular Atrophies: recent progress and revised diagnostic criteria 17-19 April 1998, Soestduinen, The Netherlands.

  1999cited by this paper
• Religion and Spirituality in the Face of Illness

  1999cited by this paper
• A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients.

  1997cited by this paper
• Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestions for a modification of existing classifications.

  1995cited by this paper

• No citing papers are available for this paper.